Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Diabetes Science and Technology

• Publication date

  2018-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1932296818758105PMID 29451006PMCID PMC6134628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Consensus on Use of Continuous Glucose Monitoring

  2017cited by this paper
• Glucose Variability

  2016cited by this paper
• Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2016cited by this paper
• Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

  2016cited by this paper
• Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes

  2016cited by this paper
• Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study

  2016cited by this paper
• Relationships among different glycemic variability indices obtained by continuous glucose monitoring.

  2015cited by this paper
• Glycemic Variability: How Do We Measure It and Why Is It Important?

  2015cited by this paper
• Utility of different glycemic control metrics for optimizing management of diabetes.

  2015cited by this paper
• The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes

  2015cited by this paper
• Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.

  2014cited by this paper
• Glucose Variability

  2013cited by this paper
• Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

  2013cited by this paper
• Glucose Variability Assessed by Low Blood Glucose Index Is Predictive of Hypoglycemic Events in Patients With Type 1 Diabetes Switched to Pump Therapy

  2013cited by this paper
• Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile

  2013cited by this paper
• Classification accuracy and cut point selection

  2012cited by this paper
• The Challenges of Measuring Glycemic Variability

  2012cited by this paper
• Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data

  2012cited by this paper
• Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability

  2011cited by this paper
• The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes

  2011influential reference
• The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

  2010cited by this paper
• 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

  2000cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.

  1998cited by this paper
• Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.

  1997cited by this paper
• Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data.

  1994cited by this paper

• The usefulness of continuous glucose monitoring in the diagnostic approach to hypoglycemia after metabolic surgery

  2025cites this paper
• Glycemic variability and mortality in critically ill patients: higher risk in non-diabetic patients

  2025cites this paper
• When would I be surprised? Variability in predicted probability of survival for being “surprised” and “not surprised” to the surprise question

  2025cites this paper
• A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target

  2025cites this paper
• Predictors of Hypoglycemia in Patients with Type 2 Diabetes in Acute Care Settings: A Retrospective Correlational Study

  2025cites this paper
• Assessment of Correlation Between Glycaemic Variability Indices and Measures of Hypoglycaemia in Patients with Type 2 Diabetes Mellitus

  2024cites this paper
• Perioperative Glycemic Variability Influences Infection Rates Differently Following Revision Hip and Knee Arthroplasty.

  2024cites this paper
• Development and Validation of a Nocturnal Hypoglycaemia Risk Model for Patients With Type 2 Diabetes Mellitus

  2024cites this paper
• Personal and Social-Built Environmental Factors of Glucose Variability Among Multiethnic Groups of Adults With Type 2 Diabetes: Research Protocol Using Ecological Momentary Assessment, Continuous Glucose Monitoring, and Actigraphy.

  2024cites this paper
• Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be

  2024cites this paper
• Current landscape and comprehensive management of glycemic variability in diabetic retinopathy

  2024cites this paper
• Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus

  2024cites this paper
• Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects

  2024cites this paper
• Influencing the Insulin System by Placebo Effects in Patients With Diabetes Type 2 and Healthy Controls: A Randomized Controlled Trial

  2023cites this paper
• Associations between sleep characteristics and glycemic variability in youth with type 1 diabetes.

  2023cites this paper
• How to Measure Glycemic Variability? A Literature Review

  2023cites this paper
• Evaluation of Glycemic Variability and Discharge Outcomes in Patients with Ischemic Stroke Following Thrombolysis

  2023cites this paper
• Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial

  2023cites this paper
• Medical Certification of Pilots Through the Insulin-Treated Diabetes Mellitus Protocol at the FAA.

  2022cites this paper
• Mining associations between glycemic variability in awake-time and in-sleep among non-diabetic adults

  2022cites this paper
• Glycemic Variability in Type 1 Diabetes Mellitus Pregnancies—Novel Parameters in Predicting Large-for-Gestational-Age Neonates: A Prospective Cohort Study

  2022cites this paper
• The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study

  2021cites this paper
• Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications

  2021cites this paper
• Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections

  2021cites this paper
• Clinical Factors Associated with High Glycemic Variability Defined by Coefficient of Variation in Patients with Type 2 Diabetes

  2021cites this paper
• Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program

  2021cites this paper
• The Role of Glycemic Variability in Cardiovascular Disorders

  2021cites this paper
• The Association Between Mean Glycated Haemoglobin or Glycaemic Variability and the Development of Retinopathy in People with Diabetes: A Retrospective Observational Cohort Study

  2021cites this paper
• MDER_A_288526 97..103

  2021cites this paper
• Rapid Response Metrics of glucose control and complications of diabetes

  2021cites this paper
• DMSO_A_257096 3221..3229

  2020cites this paper
• [The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus].

  2020cites this paper
• Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes

  2020cites this paper
• Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension

  2020cites this paper
• Glycemic variability: adverse clinical outcomes and how to improve it?

  2020cites this paper
• Comparison of Glycemic Variability Indices Blood Glucose Risk Index and Coefficient of Variation in Predicting Adverse Outcomes for Patients Undergoing Cardiac Surgery.

  2020cites this paper
• The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial.

  2020cites this paper
• Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.

  2020cites this paper
• Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.

  2019cites this paper
• Exposure to recurrent hypoglycemia alters hippocampal metabolism in treated streptozotocin‐induced diabetic rats

  2019cites this paper
• Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia

  2019cites this paper
• Relevancia del monitoreo continuo de glucosa en la práctica clínica: revisión de la evidencia

  2018cites this paper
• The C-peptide correlations and effect on the glycemic variability parameters in patients with type 2 diabetes

  2018cites this paper
• Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring

  2018cites this paper
• Glucose Variability: A Review of Clinical Applications and Research Developments

  2018cites this paper
• The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice.

  2018cites this paper
• Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

  2018cites this paper